| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 1704-1710, Copyright © 1996 by Endocrine Society
ARTICLES |
SL Blethen, DB Allen, D Graves, G August, T Moshang and R Rosenfeld
Department of Pediatrics, State University of New York, Stony Brook 11794-8111, USA.
The National Cooperative Growth Study has monitored the safety of recombinant human GH (rhGH) since 1985. Data have been collected from more than 19,000 children representing over 47,000 patient-years of rhGH treatment. Children receiving GH for renal disease were more likely to develop problems such as intracranial hypertension than those with GH deficiency (P < 0.01). Children with idiopathic short stature were less likely to develop slipped capital femoral epiphysis than those with GH deficiency or Turner's syndrome (P < 0.01). There was no evidence of an increased recurrence of leukemia or central nervous system tumors. There were 3 new cases of leukemia in children without known risk factors for developing leukemia and 5 cases in children with known risk factors. Growth deceleration associated with high affinity, high capacity antibodies to GH was found in only 2 of 5039 subjects tested (0.04%). Major adverse events in association with rhGH treatment have been rare, and preexisting medical conditions such as renal insufficiency may affect their frequency.
This article has been cited by other articles:
 |
|
 |
|
  D. S. Hardin, S. F. Kemp, and D. B. Allen Twenty Years of Recombinant Human Growth Hormone in Children: Relevance to Pediatric Care Providers Clinical Pediatrics, May 1, 2007; 46(4): 279 - 286. [Abstract] [PDF]
|
|
|
|
 |
|
 M D C Donaldson, E J Gault, K W Tan, and D B Dunger Optimising management in Turner syndrome: from infancy to adult transfer Arch. Dis. Child., June 1, 2006; 91(6): 513 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Quigley, A. M. Gill, B. J. Crowe, K. Robling, J. J. Chipman, S. R. Rose, J. L. Ross, F. G. Cassorla, A. M. Wolka, J. M. Wit, et al. Safety of Growth Hormone Treatment in Pediatric Patients with Idiopathic Short Stature J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5188 - 5196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Kemp, J. Kuntze, K. M. Attie, T. Maneatis, S. Butler, J. Frane, and B. Lippe Efficacy and Safety Results of Long-Term Growth Hormone Treatment of Idiopathic Short Stature J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5247 - 5253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Finkelstein, T. F. Imperiale, T. Speroff, U. Marrero, D. J. Radcliffe, and L. Cuttler Effect of Growth Hormone Therapy on Height in Children With Idiopathic Short Stature: A Meta-analysis Arch Pediatr Adolesc Med, March 1, 2002; 156(3): 230 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bechtold, O. Butenandt, A. Meidert, K.-P. Boergen, and H. Schmidt Persistent Papilledema in Ulirich-Turner Syndrome Treated with Growth Hormone Clinical Pediatrics, November 1, 2001; 40(11): 629 - 631. [PDF]
|
|
|
|
|
|
E. O. Reiter, K. M. Attie, T. Moshang Jr., B. L. Silverman, S. F. Kemp, R. B. Neuwirth, K. M. Ford, and P. Saenger A Multicenter Study of the Efficacy and Safety of Sustained Release GH in the Treatment of Naive Pediatric Patients with GH Deficiency J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4700 - 4706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Drake, S. J. Howell, J. P. Monson, and S. M. Shalet Optimizing GH Therapy in Adults and Children Endocr. Rev., August 1, 2001; 22(4): 425 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Taha, W. Bastian, and S. Castells Growth Hormone Replacement Therapy in Children with Leukemia in Remission Clinical Pediatrics, August 1, 2001; 40(8): 441 - 445. [Abstract] [PDF]
|
|
|
|
 |
|
 M. P. Wajnrajch, J. M. Gertner, Z. Huma, J. Popovic, K. Lin, P. C. Verlander, S. D. Batish, P. F. Giampietro, J. G. Davis, M. I. New, et al. Evaluation of Growth and Hormonal Status in Patients Referred to the International Fanconi Anemia Registry Pediatrics, April 1, 2001; 107(4): 744 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Chernausek, K. M. Attie, J. F. Cara, R. G. Rosenfeld, and J. Frane Growth Hormone Therapy of Turner Syndrome: The Impact of Age of Estrogen Replacement on Final Height J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2439 - 2445. [Abstract] [Full Text]
|
|
|
|
|
|
H. Guyda Four Decades of Growth Hormone Therapy for Short Children: What Have We Achieved? J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4307 - 4316. [Full Text]
|
|
|
|
 |
|
 M. L. Vance and N. Mauras Growth Hormone Therapy in Adults and Children N. Engl. J. Med., October 14, 1999; 341(16): 1206 - 1216. [Full Text] [PDF]
|
|
|
|
|
|
D. Wyatt Melanocytic Nevi in Children Treated With Growth Hormone Pediatrics, October 1, 1999; 104(4): 1045 - 1050. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Nishi, T. Tanaka, K. Takano, K. Fujieda, Y. Igarashi, K. Hanew, T. Hirano, S. Yokoya, K. Tachibana, T. Saito, et al. Recent Status in the Occurrence of Leukemia in Growth Hormone-Treated Patients in Japan J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1961 - 1965. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Rosenberg, W. Kingma, M. A. Fitzpatrick, and S. M. Richards Immunosurveillance of Alglucerase Enzyme Therapy for Gaucher Patients: Induction of Humoral Tolerance in Seroconverted Patients After Repeat Administration Blood, March 15, 1999; 93(6): 2081 - 2088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Saenger, K. M. Attie, J. DiMartino-Nardi, R. Hintz, L. Frahm, and J. W. Frane Metabolic Consequences of 5-Year Growth Hormone (GH) Therapy in Children Treated with GH for Idiopathic Short Stature J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3115 - 3120. [Abstract] [Full Text]
|
|
|
|
|
|
M. H. MacGillivray, S. L. Blethen, J. G. Buchlis, R. R. Clopper, D. E. Sandberg, and T. A. Conboy Current Dosing of Growth Hormone in Children With Growth Hormone Deficiency: How Physiologic? Pediatrics, August 1, 1998; 102(2): 527 - 530. [Abstract] [Full Text]
|
|
|
|
|
|
S J Howell, P Wilton, and S M Shalet Growth hormone replacement in patients with Langerhan's cell histiocytosis Arch. Dis. Child., May 1, 1998; 78(5): 469 - 473. [Abstract] [Full Text]
|
|
|
|
|
|
A. W. Root Does Growth Hormone Have a Role in the Management of Children with Nongrowth Hormone Deficient Short Stature and Intrauterine Growth Retardation? J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1067 - 1069. [Full Text]
|
|
|
|
|
|
P. V. Carroll, E. R. Christ the members of Growth Hormone Research Soci, B. A. Bengtsson, L. Carlsson, J. S. Christiansen, D. Clemmons, R. Hintz, K. Ho, Z. Laron, P. Sizonenko, et al. Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 382 - 395. [Abstract] [Full Text]
|
|
|
|
|
|
F. M. Uckun, M. G. Sensel, L. Sun, P. G. Steinherz, M. E. Trigg, N. A. Heerema, H. N. Sather, G. H. Reaman, and P. S. Gaynon Biology and Treatment of Childhood T-Lineage Acute Lymphoblastic Leukemia Blood, February 1, 1998; 91(3): 735 - 746. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Gerard, L. Garibaldi, S. E. Myers, T. Aceto JR, S. Kotagal, V. P. Gibbons, J. Stith, and C. Weber Sleep Apnea in Patients Receiving Growth Hormone Clinical Pediatrics, June 1, 1997; 36(6): 321 - 326. [Abstract] [PDF]
|
|
|
|
 |
|
 F. I. Sharara and L. C. Giudice Role of Gorwth Hormone in Ovarian Physiology and Onest of Puberty Reproductive Sciences, January 1, 1997; 4(1): 2 - 7. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
